The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Cognitive Dysfunction in Major Depressive Disorder: A State-of-the-Art Clinical Review
Abstract
Major depressive disorder (MDD) is a prevalent and recurring mental disorder often associated with high rates of non-recovery and substantial consequences on psychosocial outcome. Cognitive impairment is one of the most frequent residual symptoms of MDD. The persistence of cognitive impairment even in remitted phases of the disorder, notably in the domains of executive function and attention, suggests that it may serve as a mediational nexus between MDD and poor functional outcome, accounting for occupational and relational difficulties regardless of clinical improvement on depressive symptoms. The critical impact of cognitive deficits on psychosocial dysfunction invites clinicians to regularly screen and assess cognition across multiple domains, taking into account also clinical correlates of cognitive dysfunction in MDD. Despite the availability of several instruments for the screening and assessment of cognitive dysfunction, the lack of consensus guiding the choice of appropriate instruments increases the likelihood to underestimate cognitive dysfunction in MDD in clinical settings. On the other hand, the unsatisfactory effect of most antidepressant treatments on cognitive deficits for many individuals with MDD calls for the development of genuinely novel therapeutic agents with potential to target cognitive dysfunction. Notwithstanding the necessity of further investigations, this review indicates that neuropsychological deficits (e.g., impaired executive functions) are stable markers of MDD and underscores the need for the development of integrative and multi-modal strategies for the prevention and treatment of neuropsychological impairments in MDD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“cognitive dysfunction secondary to TCA use has long been suggested secondary to the anti-cholinergic effects of TCAs (Baune and Renger, 2014; Bortolato et al., 2014; Keefe et al., 2014).”
From The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials (2016) · cites this paper as Bortolato et al., 2014
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · cited 1×
“Clinician-rated global measures of cognition are useful short time-consuming screening tools for cognitive performance, although their use is more frequently reported in elderly samples or subpopulations capable of short-time cooperation [63].”
BackgroundSleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411 · cited 1×
“Moreover, sleep may counteract the neurotoxic effects of MDD [30] by enhancing the clearance of neurotoxins [144].”
BackgroundToward the future of psychiatric diagnosis: the seven pillars of RDoC
Cuthbert, B. N., & Insel, T. R. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-126 · Cited by 3,053
The Cognitive Failures Questionnaire (CFQ) and its correlates
Broadbent, D. E., Cooper, P. F., FitzGerald, P., & Parkes, K. R. (1982) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.1982.tb01421.x · Cited by 2,912 · cited 1×
“For example, negative affective experiences and low mood influence the report of perceived deficits in the “Cognitive Failures Questionnaire” [58], a scale of 25 questions about the frequency of failures in perception, memory, and motor function [59], and in the “Perceived Deficits Questionnaire”, a 20-item scale asse…”
BackgroundThe Epidemiology of Depression Across Cultures
Kessler, R. C., & Bromet, E. J. (2013) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031912-114409 · Cited by 2,657 · cited 1×
“Major depressive disorder (MDD) affects approximately one in seven individuals in a lifetime and is associated with high rates of recurrence, non-recovery, and illness-associated burden [1-3].”
BackgroundCognition and Depression: Current Status and Future Directions
Gotlib, I. H., & Joormann, J. (2010) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.121208.131305 · Cited by 2,420 · cited 1×
“While ‘hot’ cognitive deficits in MDD refer to a negative-biased pattern of response to stimuli on tasks of attention [16] and working memory [17] in association with rumination and high levels of criticism [18], ‘cold’ cognitive dysfunction refers to quantitative deficits on measures of”
BackgroundCognitive impairment in depression: a systematic review and meta-analysis
Rock, P. L., Roiser, J. P., Riedel, W. J., & Blackwell, A. D. (2014) · Psychological Medicine · doi:10.1017/s0033291713002535 · Cited by 2,161 · cited 5×
“, the Cambridge Neuropsychological Test Automated Battery) [14].”
BackgroundMethodResultInfluentialAdverse childhood experiences, allostasis, allostatic load and age-related disease
Danese, A., & McEwen, B. S. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.08.019 · Cited by 2,140 · cited 1×
“Early establishment of metabolic-inflammatory dysfunction may translate into long-lasting neuroendocrineimmune alterations [97], including the hyperactivity of the hypothalamic-pituitary-adrenocortical axis and glucocorticoid resistance [98], multiple alterations in innate and adaptive immunity, as well as abnormal in…”
BackgroundSnyder, H. R. (2013) · Psychological Bulletin · doi:10.1037/a0028727 · Cited by 1,667 · cited 3×
“[19] 113 studies (N=3,936 adults patients, mean age 45 y; 3,771 healthy controls, mean age 46 years) Impaired executive function and psychomotor speed (Cohen's d effect sizes ranging from 0.”
BackgroundImmune modulation of learning, memory, neural plasticity and neurogenesis
Yirmiya, R., & Goshen, I. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.015 · Cited by 1,483
Cited by
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Self-citationCognitive function following a major depressive episode: a systematic review and meta-analysis
Semkovska, M., Quinlivan, L., O'Grady, T., Johnson, R., Collins, A., O'Connor, J., Knittle, H., Ahern, E., & Gload, T. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30291-3 · Cited by 631
Ashdown-Franks, G., Firth, J., Carney, R., Carvalho, A. F., Hallgren, M., Koyanagi, A., Rosenbaum, S., Schuch, F. B., Smith, L., Solmi, M., et al. (2020) · Sports Medicine · doi:10.1007/s40279-019-01187-6 · Cited by 460
Self-citationSolmi, M., Murru, A., Pacchiarotti, I., Undurraga, J., Veronese, N., Fornaro, M., Stubbs, B., Monaco, F., Vieta, E., Seeman, M., et al. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s117321 · Cited by 438
Self-citationToward clinical digital phenotyping: a timely opportunity to consider purpose, quality, and safety
Huckvale, K., Venkatesh, S., & Christensen, H. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0166-1 · Cited by 433
Metadata
- Authors
- Bortolato, B., Carvalho, A., & McIntyre, R.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- McIntyre, Roger
- Venue
- CNS & Neurological Disorders - Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2015-01-22
- Volume
- 13
- Issue
- 10
- Pages
- 1804-1818
- ISSN
- 1568-007X (ISSN-L)
- 1871-5273
- OpenAlex
- W2156826191
- Semantic Scholar
- eb098442732350cb8b8f826a824600e94aaf86fa
- Cited by
- 181
- References
- 165
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 8 · 2023: 9 · 2022: 16 · 2021: 17 · 2020: 18 · 2019: 29 · 2018: 31 · 2017: 17 · 2016: 12 · 2015: 8
- FWCI
- 16.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS & Neurological Disorders - Drug Targets (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- major depressive disorder, cognitive impairment, executive function, attention deficits, residual cognitive impairment, remitted depression, psychosocial outcomes, cognitive screening tools, neuropsychological deficits, cognitive impairment treatment
- MeSH terms
- Clinical Trials as Topic, Cognition Disorders, Major Depressive Disorder, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cognitive Dysfunction in Major Depressive Disorder: A State-of-the-Art Clinical Review. https://app.cochat.ai/papers/10.2174/1871527313666141130203823
- The paper
- Bortolato, B., Carvalho, A., & McIntyre, R. (2015). Cognitive Dysfunction in Major Depressive Disorder: A State-of-the-Art Clinical Review. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/1871527313666141130203823
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.